Stockreport

Serina Therapeutics to Present at the 5th LNP Formulation & Process Development Summit

Serina Therapeutics, Inc.  (SER) 
PDF – Novel lipid nanoparticles entirely built on the POZ Platform that overcome the PEG immunogenicity dilemma – Design & synthesis of novel ionizable POZ lipids to repla [Read more]